Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INFORMATION SERVICES GROUP INC. (III)

  • Business News
  • June 26, 2026, 14:00 UTC
  • 3
  • 1 comments

Insurance Advisors Advance Global AI Transformations

Market reaction Comment Full text

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • June 26, 2026, 13:55 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 26, 2026, 13:50 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 26, 2026, 13:49 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP INVESTMENTS VCC (CYC)

  • Business News
  • June 26, 2026, 13:49 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 26, 2026, 13:48 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • June 26, 2026, 13:48 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • June 26, 2026, 13:47 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

NOVARTIS AG (NVSEF)

  • Business News
  • June 26, 2026, 13:45 UTC
  • 2
  • 1 comments

Clinical trial NCT07630961 updates: 1. start date: 2026-06-15 → 2026-06-23 2. completion date: 2028-01-14 → 2028-01-22 3. primary completion date: 2028-01-14 → 2028-01-22

Market reaction Comment Full text

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

  • Business News
  • June 26, 2026, 13:45 UTC
  • 2
  • 1 comments

Clinical trial NCT06347133: primary completion date: 2026-05-01 → 2026-06-01.

Market reaction Comment Full text
  • Previous
  • 3416
  • 3417
  • 3418
  • 3419
  • 3420
  • Next

Search

News categories

  • Technical Exchange News(14594)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235104)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin